Henry Schein stock is trading -6.76% below its average target price of $73.23 after marking a 1.4% during today's morning session. Analysts are giving the Mid-Cap Medical Specialities company an average rating of hold and target prices ranging from $55.0 to $83.0 per share.
The stock has an above average percentage of its shares sold short at 8.2%, and a short ratio of 4.28. Only 0.87% of the company's shares are owned by insiders, indicating that management does not have a deep alignment of interest with its shareholders. Finally, we also note that a significant number of institutional investors are invested in the stock, with 114.2% of Henry Schein's shares being owned by this investor type.
Institutions Invested in Henry Schein
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-06-30 | Kohlberg Kravis Roberts & Co. L.P. | 13% | 15,652,032 | $1,068,720,725 |
| 2025-06-30 | Vanguard Group Inc | 11% | 12,931,701 | $882,976,528 |
| 2025-06-30 | Blackrock Inc. | 6% | 7,302,756 | $498,632,170 |
| 2025-06-30 | Artisan Partners Limited Partnership | 5% | 6,462,204 | $441,239,281 |
| 2025-06-30 | JPMORGAN CHASE & CO | 5% | 6,252,743 | $426,937,284 |
| 2025-06-30 | Laurel Wealth Advisors LLC | 5% | 6,085,000 | $415,483,792 |
| 2025-06-30 | State Street Corporation | 4% | 5,226,625 | $356,873,948 |
| 2025-06-30 | American Century Companies Inc | 4% | 4,558,790 | $311,274,175 |
| 2025-06-30 | Invesco Ltd. | 4% | 4,546,935 | $310,464,716 |
| 2025-06-30 | FMR, LLC | 3% | 3,708,752 | $253,233,582 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Henry Schein.
